SET Domain, Bifurcated 2 (SETDB2) Peptide
SETDB2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all SETDB2 products
- SETDB2 (SET Domain, Bifurcated 2 (SETDB2))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- ASQKEVNAQS SDPMPVTQKE QENKSNAFPS TSCENSFPED CTFLTTGNKE
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SETDB2 antibody,
Alternative Names: SETDB2 control peptide, SETDB2 antibody Blocking Peptide, Anti-SETDB2 Blocking Peptide, Set Domain Bifurcated 2 Blocking Peptide, SETDB2, SETDB-2, SETDB 2, SETDB-2 Blocking Peptide, SETDB 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- SETDB2 (SET Domain, Bifurcated 2 (SETDB2))
- Synonyms
- C13orf4 Peptide, CLLD8 Peptide, CLLL8 Peptide, KMT1F Peptide, Clld8 Peptide, Gm293 Peptide, SET domain bifurcated 2 Peptide, SET domain, bifurcated 2 Peptide, SETDB2 Peptide, Setdb2 Peptide
- Background
- Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity.
- Molecular Weight
- 77 kDa
-
You are here:
